Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06930638
PHASE2

MitoQ and Ischemic Conditioning To Assess Vascular Health Outcomes

Sponsor: Medical College of Wisconsin

View on ClinicalTrials.gov

Summary

Stroke survivors have compromised vascular function which may contribute to secondary stroke risk, cardiovascular disease, and may limit their exercise tolerance. Preliminary data shows a single bout of ischemic conditioning or oral ingestion of an over-the-counter antioxidant supplement called MitoQ may improve vascular function and muscle activity in individuals post-stroke.

Official title: MitoQ and Ischemic Conditioning To Assess Vascular Health Outcomes (MITO Study)

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-07-22

Completion Date

2026-12-31

Last Updated

2025-09-25

Healthy Volunteers

No

Conditions

Interventions

DEVICE

Ischemic Conditioning

The cuff will be placed around the proximal, non-affected thigh and inflated for 5 minutes in a supine or semi-reclined position, then released for a 5-minute recovery period. Five cycles of inflation and recovery will be performed (45 minutes total).These inflations will be done using a cuff similar to what is used for taking blood pressure.

DIETARY_SUPPLEMENT

Antioxidant Supplement

MitoQ is an over the counter supplement that increases delivery to the mitochondria. Similar to studies performed in middle age/older adults and individuals with peripheral arterial disease, we will administer 1 single oral dose of 80mg of MitoQ or a placebo pill. As MitoQ reaches peak concentrations at \~40 to 60 minutes after ingestion, we will wait 45 minutes (time matched to Ischemic conditioning).

Locations (1)

Medical College of Wisconsin

Milwaukee, Wisconsin, United States